Literature DB >> 24319248

Mechanisms of trauma-induced coagulopathy.

Nathan J White1.   

Abstract

The identification and management of coagulopathy is a critical component of caring for the severely injured patient. Notions of the mechanisms of coagulopathy in trauma patients have been supplanted by new insights resulting from close examination of the biochemical and cellular changes associated with acute tissue injury and hemorrhagic shock. Acute intrinsic coagulopathy arising in severely injured trauma patients is now termed trauma-induced coagulopathy (TIC) and is an emergent property of tissue injury combined with hypoperfusion. Mechanisms contributing to TIC include anticoagulation, consumption, platelet dysfunction, and hyperfibrinolysis. This review discusses current understanding of TIC mechanisms and their relative contributions to coagulopathy in the face of increasingly severe injury and highlights how they interact to produce coagulation system dysfunction.

Entities:  

Mesh:

Year:  2013        PMID: 24319248     DOI: 10.1182/asheducation-2013.1.660

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  11 in total

1.  Adhesion of Blood Clots Can Be Enhanced When Copolymerized with a Macromer That Is Crosslinked by Coagulation Factor XIIIa.

Authors:  Karen Y T Chan; Chunyi Zhao; Erika M J Siren; Jeanne C Y Chan; Jeffrey Boschman; Christian J Kastrup
Journal:  Biomacromolecules       Date:  2016-05-17       Impact factor: 6.988

Review 2.  TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy.

Authors:  K G Mann; K Freeman
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

3.  [Thrombosis and post-thrombotic syndrome as a consequence of an accident].

Authors:  U Wahl; T Hirsch
Journal:  Unfallchirurg       Date:  2015-10       Impact factor: 1.000

4.  A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments.

Authors:  Ann R Kennedy; Amit Maity; Jenine K Sanzari
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

5.  Insufficient fibrinogen response following free flap surgery is associated with bleeding complications.

Authors:  Jonas Kolbenschlag; Yannick Diehm; Adrien Daigeler; David Kampa; Sebastian Fischer; Nicolai Kapalschinski; Ole Goertz; Marcus Lehnhardt
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-11-22

6.  Overexpression of miR-24 Is Involved in the Formation of Hypocoagulation State after Severe Trauma by Inhibiting the Synthesis of Coagulation Factor X.

Authors:  Lu-Jia Chen; Lian Yang; Xing Cheng; Yin-Kai Xue; Li-Bo Chen
Journal:  Dis Markers       Date:  2017-06-14       Impact factor: 3.434

7.  Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage.

Authors:  Hayley Letson; Geoffrey Dobson
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

8.  A case report: Veno-venous extracorporeal membrane oxygenation for severe blunt thoracic trauma.

Authors:  Fumihiro Ogawa; Takuma Sakai; Ko Takahashi; Makoto Kato; Keishi Yamaguchi; Sayo Okazaki; Takeru Abe; Masayuki Iwashita; Ichiro Takeuchi
Journal:  J Cardiothorac Surg       Date:  2019-05-06       Impact factor: 1.637

9.  The impact of early thromboelastography directed therapy in trauma resuscitation.

Authors:  Mohamed Mohamed; Karl Majeske; Gul R Sachwani; Kristin Kennedy; Mina Salib; Michael McCann
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-10-05       Impact factor: 2.953

10.  Assessment of Coagulation Homeostasis in Blunt, Penetrating, and Thermal Trauma: Guidance for a Multicenter Systems Biology Approach.

Authors:  Jeffrey W Shupp; Kathleen E Brummel-Ziedins; Mitchell J Cohen; Kalev Freeman; Rasha Hammamieh; Uma S Mudunuri; Thomas Orfeo; Lauren T Moffatt; Bernard H Brownstein; Kenneth G Mann; Marti Jett; Anthony E Pusateri
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.